FindTrial
Sign In

Ketamine nebulisation in Post-operative sore throat

Dose-dependent effectiveness of Ketamine nebulisation in preventing post-operative sore throat due to tracheal intubation: A Prospective Randomised Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/011009
Enrollment
90
Registered
2017-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- post operative sore throat

Interventions

Intervention1: preservative free Ketamine: 0.5 mg/kg, Aneket 50 mg/ml, 2ml ampoule, Neon Laboratories Ltd Control Intervention1: preservative free Ketamine : 1 mg/kg, Aneket 50 mg/ml, 2ml ampoule, Neo

Sponsors

Dr Madhava Reddy R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA physical status 1 and 2 2. patients undergoing surgeries in supine position under general Anaesthesia 3. surgeries lasting more than one hour

Exclusion criteria

Exclusion criteria: 1. Patients with Mallampati class greater than 2 2. pre-operative sore throat, 3. allergy to study drug, 4. recent history of NSAID medication, 5. smokers, asthmatics, patients with COPD, 6.head and neck surgeries, 7.those who require more than two attempts at intubation, 8.surgeries requiring nasogastric tube and throat pack insertion. 9.Patients in whom extubation caused coughing or bucking.

Design outcomes

Primary

MeasureTime frame
post operative sore throat at 4 hoursTimepoint: 4 hours—

Secondary

MeasureTime frame
post operative sore throat at 0, 2, 6,8, 12, 24 hoursTimepoint: 0, 2, 6,8, 12, 24 hours—

Countries

India

Contacts

Public ContactDr Madhava Reddy R

Kempegowda Institute of Medical Sciences, Bangalore

madhavareddy.r@gmail.com9379094790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026